Evidence map›Paper›PMID 17602897›Full record

ArticleDNA repair2007

A mutation in EXO1 defines separable roles in DNA mismatch repair and post-replication repair.

Phuoc T Tran, Julien P Fey, Naz Erdeniz, Lionel Gellon, Serge Boiteux, R Michael Liskay

Open access · greenAbstract read
In one paragraph

Article in DNA repair, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 59 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Exonuclease 1 (Exo1) Participates in Mammalian Non-Homologous End Joining and Contributes to Drug Resistance in Ovarian Cancer.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Reconstitution ofProceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Phuoc T TranDepartment of Radiation Oncology, Stanford Hospital & Clinics, Stanford, CA 94305, USA.
Julien P Fey
Naz Erdeniz
Lionel Gellon
Serge Boiteux
R Michael Liskay
Oregon Health & Science University · USCornell University · USHarvard University Press · USStanford Health Care · US

Funding

HOMOLOGOUS RECOMBINATION IN MAMMALIAN CELLSR01GM045413 · NIGMS · YALE UNIVERSITY · PI LISKAY, ROBERT MICHAEL · 1991 to 2006
$2.0M
NIGMS NIH HHS GM45413NIGMS NIH HHS R01 GM045413
6 · The paper itself

Abstract

Replication forks stall at DNA lesions or as a result of an unfavorable replicative environment. These fork stalling events have been associated with recombination and gross chromosomal rearrangements. Recombination and fork bypass pathways are the mechanisms accountable for restart of stalled forks. An important lesion bypass mechanism is the highly conserved post-replication repair (PRR) pathway that is composed of error-prone translesion and error-free bypass branches. EXO1 codes for a Rad2p family member nuclease that has been implicated in a multitude of eukaryotic DNA metabolic pathways that include DNA repair, recombination, replication, and telomere integrity. In this report, we show EXO1 functions in the MMS2 error-free branch of the PRR pathway independent of the role of EXO1 in DNA mismatch repair (MMR). Consistent with the idea that EXO1 functions independently in two separate pathways, we defined a domain of Exo1p required for PRR distinct from those required for interaction with MMR proteins. We then generated a point mutant exo1 allele that was defective for the function of Exo1p in MMR due to disrupted interaction with Mlh1p, but still functional for PRR. Lastly, by using a compound exo1 mutant that was defective for interaction with Mlh1p and deficient for nuclease activity, we provide further evidence that Exo1p plays both structural and catalytic roles during MMR.

Indexed as

DNA Mismatch RepairMutationAllelesDNA ReplicationExodeoxyribonucleasesMethyl MethanesulfonateSaccharomyces cerevisiaeexodeoxyribonuclease IExodeoxyribonucleasesMethyl Methanesulfonate

Identifiers

PMID17602897
PMCPMC2447855
OpenAlexW2002450241

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.